Drugs / GK01
GK01
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 03 trials | ||||||
| Phase 0 | NCT07673419 | Jul 2026 → Jun 2028 expected | lung cancer | Beijing Geekgene Technology Co., LTD | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT07412665 | Jun 2026 → Mar 2027 expected | cancer | Beijing Geekgene Technology Co., LTD | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT07414316 | Feb 2026 → Feb 2027 expected | cancer | Beijing Geekgene Technology Co., LTD | Recruiting | No outcome recorded |
| Phase 13 trials | ||||||
| Phase 1 | NCT07407985 | Dec 2025 → Dec 2027 expected | cancer | Tianjin Medical University Cancer Institute and Hospital | Active not recruiting | No outcome recorded |
| Phase 1 | NCT07351903 | Oct 2025 → Oct 2028 expected | cancer | Tianjin Medical University Cancer Institute and Hospital | Recruiting | No outcome recorded |
| Phase 1 | NCT06954558 | Mar 2025 → Mar 2028 expected | — | Tianjin Medical University Cancer Institute and Hospital | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GK01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07414316 ↗ |
| Known as | GK01 Cell Injection | “A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer” NCT07673419 ↗ |
| Known as | GK01 Injection | “Drug: GK01 Injection” NCT07673419 ↗ |
| Modality | Cell therapy | “Autologous tumor-reactive T cells injection” NCT06954558 ↗ |